关于博奥ABOUT

博奥颐和携手台塑集团协力推动大健康产业发展

2016年四季度   

导读:博奥颐和将与台塑集团通力合作,共同致力于两岸预防医学、抗老化的大健康产业发展。
CapitalBio eHealth and Formosa Plastics Group will join effort to push forward the big health industry development in preventive medicine and anti-aging care.

 

508839643482860242

博奥颐和健康科学技术(北京)有限公司副总裁兼科学总监孙义民博士与台塑集团总管理处医学事业发展中心经理蔡孝玮博士签订双方合作备忘录

2016年11月21日,博奥颐和健康科学技术(北京)有限公司与台塑集团总管理处医学事业发展中心联合签署了合作备忘录。此备忘录的签订宣布了双方共同启动战略合作伙伴关系的意向,未来将在大健康产业领域进行多方面深度合作,包括利用综合健康数据进行个体评估,为个性化疾病预防和抗老化提供解决方案。双方相信在未来两岸市场上,通过产品研发、生产、市场营销等方面的合理分工与协作,将会促进预防医学、抗老化的大健康产业的长足发展,最终实现互利共赢。

On 21st November 2016, CapitalBio eHealth and Medical Development Centre of Group Administration, Formosa Plastics Group signed a Memorandum of Understanding for an integrated Big Health Program.  It marks the initiation of a strategic partnership to develop a series of multi-facet and in-depth projects focused on preventive medicine and anti-aging care. These projects aim to provide a comprehensive health management solution based on personalised assessment using integrated health information.  It is believed that through well-planned collaborations in R&D, manufacturing and commercialisation, both parties will promote the industry development significantly by bridging the markets across the Straight of Taiwan, and achieve mutual benefits. 

668643176134324074

博奥颐和健康科学技术(北京)有限公司与台塑集团总管理处医学事业发展中心签约双方嘉宾合影

关于博奥颐和健康科学技术(北京)有限公司

About CapitalBio eHealth Science & Technology (Beijing) Co., Ltd.

博奥颐和健康科学技术(北京)有限公司(以下简称:博奥颐和)隶属清华医疗健康旗舰公司——博奥生物集团有限公司,是清华大学布局大健康领域的健康管理旗舰公司,致力于“打造以个体为中心的身心境大健康管理系统”,依托清华大学、生物芯片北京国家工程研究中心暨博奥生物集团有限公司,以生物工程、信息工程、移动互联网技术和国医治未病体系为纽带,秉承“依测而调”的理念,形成了“测、调、增”三个系列的产品体系和服务体系,全面布局大健康产业。

CapitalBio eHealth Science & Technology (Beijing) Co., Ltd. (hereinafter referred to as CapitalBioeHealth) is under CapitalBio Corporation, the flagship company of Tsinghua University in healthcare in the latter’s design of the area of big health management. The company devotes itself to “creating an individual-centric big health management system in an environment for better physical & mental health”. Relying on the foundation of Tsinghua University and Biochip Beijing National Engineering Research Center of CapitalBio Corporation Ltd., CapitalBio eHealth has established its product and service portfolio along the paradigm of “Monitoring, Conditioning and Enhancement”, and follows the concept of "conditioning based on monitoring assessment".  It focuses on the big health industry supported by biological engineering, information engineering, mobile Internet technology and Traditional Chinese Medicine for disease prevention.

关于台塑集团总管理处医学事业发展中心

About Medical Development Centre of Group Administration,Formosa Plastics Group

台塑集团拥有先进的医疗系统,长期关注全球重大医疗主题。总管理处医学事业发展中心着重于预防医学、再生医学、精准医学、以及药物开发四大领域。首重于推广普及化预防医学系统,有别于医院以治疗疾病为主的疾病预防。并计划发展以再生医学及精准医学为核心的抗老化研究中心,让健康老化的临床科学论证更为扎实。将老化中最重要的失智与失能问题,维持及延缓,实现健康老化目标。

Formosa Plastics Group has a world-leading medical system, and has long been focused on major global medical topics. The Medical Development Centre is dedicated to the development of preventive medicine, regenerative medicine, precision medicine and drug development. The Centre emphasises on broad application of a preventive medical system, differentiating itself from therapeutically oriented disease prevention from hospitals. It is also planned to develop an Anti-Aging Research Centre, themed around regenerative medicine and precision medicine, to build on and strengthen clinical evidence for healthy aging care. The Medical Development Centre of Formosa Plastics Group takes on the challenge from the loss of mental and physical abilities associated with aging, and aims to achieve the goal of healthy aging.